Network
Limitations of Current Chemotherapy Regimes Coupled With Increasing Incidence of Cancer Is Driving the Uptake of Cancer Support Therapies, States Frost & Sullivan
marketwire.com/press-release/Limitations-Current-...-With-Increasing-Incidence-Cancer-Is-1416758.htm
–
view page
–
cached page
Stringent regulatory requirements are delaying the launch of critical drugs in the oncology market. Moreover, premium pricing of products and reimbursement issues are curtailing the growth of this market. However, given the wide range of side effects that result due to cancer chemotherapy regimes, there are several different types of support therapies that can be applied to improve patients'... moreStringent regulatory requirements are delaying the launch of critical drugs in the oncology market. Moreover, premium pricing of products and reimbursement issues are curtailing the growth of this market. However, given the wide range of side effects that result due to cancer chemotherapy regimes, there are several different types of support therapies that can be applied to improve patients' quality of life. This situation is opening up considerable view page
All posts about this link
All posts about this link
Limitations of Current Chemotherapy Regimes Coupled With Increasing Incidence ...: "Current chemotherapeutic age..
Limitations of Current Chemotherapy Regimes Coupled With Increasing Incidence ...: "Current chemotherapeutic age..
Limitations of Current Chemotherapy Regimes Coupled With Increasing Incidence ...: "Current chemotherapeutic age..
#qualityoflife : Limitations of Current Chemotherapy Regimes Coupled With Increasing Incidence ..